| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.26▲ | 1.26▲ | 1.26▲ | 1.37▼ | 1.56▼ |
| MA10 | 1.28▲ | 1.28▲ | 1.29▼ | 1.51▼ | 2.15▼ |
| MA20 | 1.32▼ | 1.32▼ | 1.35▼ | 1.58▼ | 2.67▼ |
| MA50 | 1.38▼ | 1.45▼ | 1.52▼ | 2.24▼ | 1.24▲ |
| MA100 | 1.49▼ | 1.56▼ | 1.78▼ | 2.73▼ | N/A |
| MA200 | 1.62▼ | 2.09▼ | 2.55▼ | 1.50▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.004▲ | 0.004▲ | 0.004▲ | -0.269▼ |
| RSI | 43.026▼ | 40.791▼ | 37.471▼ | 29.982▼ | 40.840▼ |
| STOCH | 29.943 | 29.943 | 21.667 | 14.662▼ | 8.953▼ |
| WILL %R | -58.824 | -58.824 | -65.000 | -92.771▼ | -97.727▼ |
| CCI | -11.190 | -10.853 | -28.484 | -146.051▼ | -120.047▼ |
|
Thursday, January 22, 2026 06:44 AM
The drug discovery company, which also invests in solar energy assets, revealed that its wholly-owned subsidiary MitoCareX Bio has demonstrated in vitro inhibition of pro-inflammatory responses in ...
|
|
Thursday, January 22, 2026 04:52 AM
MITOLINE™ Algorithm Powers Development of First-in-Class Small Molecules Targeting a Mitochondrial Carrier for Inflammatory Metabolic Diseases – ...
|
|
Thursday, January 15, 2026 12:32 AM
Neve Yarak, Israel, Jan. 15, 2026 (GLOBE NEWSWIRE) -- N2OFF, Inc. (NASDAQ: NITO) (“N2OFF” and the “Company”), a drug discovery company that is also investing in solar energy assets based on the RTB ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/01/26 | 1.21 | 1.30 | 1.20 | 1.26 | 63,053 |
| 29/01/26 | 1.35 | 1.35 | 1.22 | 1.26 | 104,550 |
| 28/01/26 | 1.36 | 1.42 | 1.30 | 1.41 | 104,161 |
| 27/01/26 | 1.37 | 1.468 | 1.35 | 1.45 | 139,792 |
| 26/01/26 | 1.56 | 1.56 | 1.43 | 1.46 | 260,640 |
| 23/01/26 | 1.68 | 1.75 | 1.61 | 1.63 | 554,135 |
| 22/01/26 | 1.92 | 2.03 | 1.51 | 1.81 | 45,740,684 |
| 21/01/26 | 1.53 | 1.70 | 1.51 | 1.65 | 47,849 |
| 20/01/26 | 1.57 | 1.63 | 1.539 | 1.57 | 18,981 |
| 16/01/26 | 1.67 | 1.78 | 1.61 | 1.62 | 89,288 |
|
|
||||
|
|
||||
|
|